Next Article in Journal
Metabolomics Approach on Non-Targeted Screening of 50 PPCPs in Lettuce and Maize
Next Article in Special Issue
The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols
Previous Article in Journal
Facile Fabrication of 1-Methylimidazole/Cu Nanozyme with Enhanced Laccase Activity for Fast Degradation and Sensitive Detection of Phenol Compounds
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells

1
Team ‘Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism’ EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France
2
Laboratory of Neurophysiology, Cellular Physiopathology and Valorisation of Biomolecules, (LR18ES03), Department of Biology, Faculty of Sciences, University Tunis El Manar, Tunis 2092, Tunisia
3
Laboratoire Spiral, 21560 Couternon, France
4
Institut Européen des Antioxydants (IEA), 1B, rue Victor de Lespinats, 54230 Neuves-Maisons, France
5
Team OCS, Institute of Molecular Chemistry of University of Burgundy (ICMUB UMR CNRS 6302), University of Bourgogne Franche-Comté, 21000 Dijon, France
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(15), 4713; https://doi.org/10.3390/molecules27154713
Submission received: 23 June 2022 / Revised: 20 July 2022 / Accepted: 21 July 2022 / Published: 23 July 2022
(This article belongs to the Special Issue Targeting Oxidative Stress and Organites Associated in Disease)

Abstract

:
Trans-resveratrol is a natural polyphenol showing numerous biological properties, especially anti-tumoral and antioxidant activity. Among numerous resveratrol derivatives, aza-stilbenes, which bear an imine bound, show interesting biological activities. In the present study, we synthesized a series of imine analogs of trans-resveratrol (seven aza-stilbenes) following an easy and low-cost procedure of green chemistry. The toxicity of synthesized aza-stilbenes, which is currently unknown, was evaluated on murine neuronal N2a cells, comparatively to trans-resveratrol, by considering: cell density evaluated by staining with sulforhodamine 101; esterase activity, which is a criteria of cell viability, by staining with fluorescein diacetate; and transmembrane mitochondrial potential, which is known to decrease during cell death, by staining with DiOC6(3) using flow cytometry. In addition, the antioxidant activity was quantified with the KRL (Kit Radicaux Libres) assay, the DPPH (2,2′-diphenyl-1-picrylhydrazyl radical) assay and the FRAP (ferric reducing antioxidant power) assay. The PAOT (Pouvoir Antioxidant Total) score was also used. The aza-stilbenes provide different cytotoxic and antioxidant activities, which are either higher or lower than those of trans-resveratrol. Based on their cytotoxic and antioxidant characteristics, all synthesized aza-stilbenes are distinguished from trans-resveratrol.

Graphical Abstract

1. Introduction

Polyphenolic compounds present in numerous plants exhibit a large variety of biological properties [1]. Among them, polyphenolic stilbenoids occupy an important place in the field of health-beneficial molecules. In this series, the most-studied molecule is the trans-resveratrol (RSV) or 3,4′,5-trihydroxystilbene, a phytoalexin, present in numerous edible plants such as peanuts, red fruit including grapes and therefore in red wine.
RSV is implied in the French paradox [2,3] and in the Mediterranean diet [4,5]. The interest aroused by RSV since the 1990s [6] is especially due to its pleiotropic antifungal and therapeutic activities in the treatment of inflammatory diseases and some cancer. Unfortunately, the weak bioavailability of RSV does not allow to consider it as a perfect therapeutic molecule [7]. Indeed, RSV is rapidly metabolized and degraded [5]. Numerous synthetic derivatives of RSV were elaborated to improve and target more of some biological activities and to enhance their water solubility. Different ways to modify RSV while keeping the initial stilbenoid skeleton were reported as transformation of phenolic functions into ester or ether functions [8,9,10], or by addition of different substituents on the aromatic rings [11,12,13,14], or by changing a phenyl with an aromatic heterocycle [15] or an aromatic organometallic cycle [13]. Moreover, the C = C bond may be replaced with an isosteric fragment as an aromatic heterocycle [16], or with a C = N bond or a N = N bond to provide aza-stilbenes AZA-ST [17] and azo-stilbenes AZO-ST [18], respectively (Figure 1).
Recently, biological activities of these series of bio-isosteric resveratrol derivatives were reviewed, especially the antioxidant properties of AZA-ST [19]. Regarding resveratrol, the replacement of the C = C bond by the isosteric fragment C = N gives noteworthy behaviors to these derivatives. In addition, the presence of one or more hydroxyl groups and their position on aromatic cycles bring more or less strong antioxidant properties to aza-stilbenes. In this report, seven aza-stilbenes 1a1g were synthesized by using previously described methods, which were improved by including criteria of green chemistry [20,21,22,23,24,25] (Figure 2), and we evaluated their toxicity on murine neuronal N2a cells, comparatively to trans-resveratrol, by taking into account the following parameters: cell density evaluated by staining with sulforhodamine 101 (SR101); esterase activity, which is a criteria of cell viability, by staining with fluorescein diacetate (FDA); transmembrane mitochondrial potential (ΔΨm), which is known to decrease during cell death, by staining with 3,3′-dihexyloxacarbocyanine Iodide (DiOC6(3)) and flow cytometry; antioxidant activity was quantified with the KRL (Kit Radicaux Libres) assay as previously described [26,27] as well as with the DPPH (2,2′-diphenyl-1-picrylhydrazyl radical) assay [28] and the ferric reducing antioxidant power FRAP (ferric reducing antioxidant power) assay [29,30]. The PAOT (Pouvoir Antioxydant Total) score was also used [31].
As it is assumed that aza-stilbenes would be less degraded than trans-resveratrol both in vitro and in vivo, their use for therapeutic purposes could be considered, provided that these molecules do not exhibit a greater toxicity than that of trans-resveratrol while having retained the antioxidant properties of this one.

2. Results and Discussion

2.1. Chemistry

Aza-stilbenes may be easily synthesized by a one-step condensation reaction between aromatic aldehydes and primary aromatic amines (Scheme 1). The commercially available reactants often bear hydroxyl, methoxyl, methyl or halogenated atoms as substituents, which makes it possible to obtain a large series of aza-stilbenes. The reaction between an equimolar amount of aromatic aldehydes and primary aromatic amines may be carried out in refluxing EtOH with a catalytic amount of triethylamine [20] or of HCl [21,22]. However, aza-stilbenes may be obtained by stirring an equimolar amount of aromatic aldehydes and primary aromatic amines in a small volume of water as solvent at room temperature during 0.5 to 3 h. The products are isolated by filtration with high yields [23]. In this report, we chose this cost-effective method [24,25] that we have improved by introducing several criteria of green chemistry.
It has been shown that the antioxidant activities of trans-resveratrol (further defined as resveratrol) are often due to an OH group in position 4′ [32,33]. Thus, to keep a comparison setting between resveratrol and aza-stilbenes, AZA-ST 1ag were prepared from 4-hydroxyaniline (2) and different aromatic aldehydes 3a-g as described in Scheme 2. Compounds 1a1e have been reported by different authors [20,21]. Among them, Kotora et al. have characterized aza-stilbenes 1ad, especially by NMR spectroscopy [25]. In this report, we have carried out 1H, COSY and NOESY NMR experiments of all compounds to assign chemical shifts of aromatic protons as well as 13C, jmod, HSQC and HMBC NMR experiments to highlight coupling between the 1H and 13C nucleus.
Towards stilbenes synthesis, preparation of AZA-ST may be carried out in a one-step sustainable reaction. Indeed, synthesis of hydroxystilbenes derived from resveratrol requires several steps, including protection and deprotection reactions [11,13]. In addition, stilbenes are isolated under a mixture of both E and Z isomers, whose proportions depend on the method used (Heck or Wittig method) [13]. In contrast, in the case of AZA-ST, only the E isomers are isolated because the Z configuration is not thermally favored [34].

2.2. Cytotoxicity

Some experiments were realized to determine and compare the cytotoxic activities of aza-stilbenes 1a to 1g to resveratrol in a range of concentration from 1.5 to 100 µM (48 h). In this range of concentration, resveratrol is known to have differentiating activities on N2a cells at low concentrations (6.25 and 12.5 µM, 48 h) [35] and to induce cell death at concentrations higher than 12.5 µM [36]. In the present study, three complementary assays (SR101, FDA and DiOC6(3) assays) were used to determine the cytotoxic activities of aza-stilbenes 1a to 1g comparatively to resveratrol. Among these different assays, SR101 gives information on cell density, which reflects cell growth and cell adhesion. With the different aza-stilbenes used, as well as with resveratrol, the decrease of fluorescence observed with the SR101 assay corresponds to a decrease of cell density, which is relied with a loss of cell adhesion associated with an increasing of floating cells (dead cells) in the culture medium (Figure 3).
Based on the SR101 test, the cytotoxicity of aza-stilbenes and resveratrol were in the following range of order: resveratrol > aza-stilbene 1g > aza-stilbene 1b > aza-stilbene 1d > aza-stilbene 1c >aza-stilbene 1a > aza-stilbene 1d > aza-stilbene 1e (Figure 3). The FDA assay indicates a loss of esterase activity, obtained in the same range of concentrations as the loss of cell adhesion observed with SR101 (Figure 4). This supports that aza-stilbenes- and resveratrol-induced cell death trigger plasma-membrane damages; this agrees with the concentration-dependent decrease of esterase activity observed with the different aza-stilbenes studied and with resveratrol.
As it is well established on different cell types, including N2a cells, that resveratrol triggers mitochondrial dysfunctions in a concentration-dependent manner [36], the effects of aza-stilbenes have been studied at the mitochondrial level and compared with those of resveratrol. With the used of DiOC6(3), which allows quantifying the ΔΨm, a more or less pronounced loss of ΔΨm was observed with the different aza-stilbenes since 12.5 µM (Figure 5).
Our data show important differences of toxicity from one aza-stilbene to another. In addition, based on the different cytotoxic assays used, the most cytotoxic aza-stilbenes are aza-stilbene 1g and aza-stilbene 1b (Table 1). The toxicity of these two aza-stilbenes evocates the toxicity observed with resveratrol, whereas the toxicities of the other aza-stilbenes (1a, 1c, 1d, 1e and 1f) are lower than with resveratrol.
In addition, as resveratrol is also known for its antioxidant properties, the antioxidant activities of aza-stilbenes 1a to 1g were determined with the KRL assay and compared with resveratrol. All the aza-stilbenes considered have higher antioxidant activities than resveratrol (Figure 6). The highest antioxidant activities were observed with aza-stilbenes 1d and 1b; the antioxidant activities of aza-stilbenes (1a, 1c, 1e, 1f and 1g) were similar and lower (Figure 6).
Data obtained with the KRL assay, which integrates the ability of an antioxidant molecule to neutralize reactive oxygen species and to prevent the peroxidation of membrane lipids, were associated with two conventional antioxidant assays: the DPPH (2,2′-diphenyl-1-picrylhydrazyl radical) and the FRAP (ferric reducing antioxidant power) assays. The data obtained with the DPPH assay, which only take in consideration the ability of an antioxidant molecule to neutralize a radical, allow to distinguish the different aza-stilbenes and the resveratrol. With the DPPH assay (at the exception of aza-stilbene 1c and 1g), as observed with the KRL test, the aza-stilbenes have higher antioxidant activities than resveratrol (Table 2).
As polyphenols are known for their chelating properties towards various metals, including Fe [37], it is supposed that the antioxidant and chelating properties of polyphenols, and probably of aza-stilbenes, could interfere when the FRAP assay is used. For this reason, in agreement with this hypothesis, it was unable to discriminate the antioxidant properties of resveratrol and aza-stilbenes with this method.
The PAOT score, which has been recently described [25], was also used and compared with the KRL and DPPH assay. The PAOT score is based on the measurement of the scavenging properties of antioxidants with the use of an electrochemical method. The data obtained with resveratrol and few aza-stilbenes also allow to distinguish the molecules tested. Based on the simultaneous use of the KRL, DPPH and PAOT assay, it is considered that the aza-stilbenes 1a and 1d have the highest antioxidant activities, whereas aza-stilbene 1c has the lowest antioxidant characteristics (Table 1).
It is important to underline that some differences were observed from one antioxidant assay to another, since the different assays used to evaluate the antioxidant activities measure different parameters.
As aza-stilbenes have antioxidant activities, it will be further of interest to evaluate their differentiating activities on N2a cells to determine their neurotrophic effect (antioxidant activity + differentiating activity on nerve cells) [35,38]. This can have important applications in the context of regenerative medicine. In addition, as resveratrol has also been shown to induce the differentiation of murine myoblasts C2C12 in myotubes [39], there is also an interest to further evaluate the ability of aza-stilbenes to act on the differentiation of skeletal muscle cells. This can also have important applications in the context of aging for the treatment of sarcopenia, which is characterized by a decrease of the muscular mass in the elderly [40].

3. Conclusions

Comparatively to resveratrol (trans-resveratrol), the aza-stilbenes synthetized have either higher or lower cytotoxic and antioxidant activities. Our data show that all aza-stilbenes synthesized are distinguishable based on their cytotoxic and antioxidant activities. Thus, the aza-stilbenes produced constitute a new series of molecules for which it is therefore justified to further specify their pharmacological activities on different in vitro and in vivo disease models for which the trans-resveratrol has shown some effects such as some cancer, chronic inflammatory diseases and age-related diseases (cardiovascular diseases, ocular diseases and neurodegenerative diseases).

4. Materials and Methods

4.1. Chemistry

All reagents and solvents are purchased from commercial suppliers and used without further purifications. 4-aminophenol [123-30-8], 3-hydroxybenzaldehyde [100-83-4], salicylaldehyde [90-02-8] and 3,5-dihydroxybenzaldehyde [26153-38-8] are purchased from Alfa Aesar (ThermoFisher Scientific, Waltham, MA USA); 4-hydroxybenzaldehyde [123-08-0] and para-anisaldehyde [123-11-5] are purchased from Acros Organics (Geel/Antwerp, Belgium); 2-bromobenzaldehyde [6630-33-7] was purchased from Aldrich and 4-bromobenzaldehyde [1122-91-4] is purchased from TCI Europe (Zwijndrecht, Belgium).
The characterization of the products was established at the “Chemical Analysis Platform of Molecular Synthesis University of Burgundy (PACSMUB)”. High-resolution mass spectra (HRMS) were obtained on a Thermo LTQ-Orbitrap XL with ESI source. FTIR spectra were obtained on a Brucker Alfa spectrometer (diamond ATR, Kontich, Belgium) in the range of 400–4000 cm−1. 1H (500 MHz) and 13C (126 MHz) NMR spectra were recorded on Brucker 500 MHz spectrometer. The chemical shifts are given in ppm relative to DMSO d6 (1H, 3.33 and 2.50 ppm and 13C 39.52 ppm). Coupling constants J are given in Hz. Multiplicities are given as follows: singlet (s), doublet (d), triplet (t), quadruplet (q) and multiplet (m). “CPh” designates protons and carbons of the aromatic ring bound to the carbon atom of imine, and “NPh” designates protons and carbons of the aromatic ring bound to the nitrogen atom of imine (Figure 7).
General procedure for the synthesis of (hydroxyphenyliminomethyl)phenols1a1g.
4-aminophenol (2) (1 g, 9.17 mmol) was stirred with an equimolar amount of an aromatic aldehyde 3ag in 20 mL of distillated water, during 4 to 5 h at room temperature (20 °C). The solid product obtained 1a1g was filtered, washed with water, air dried and recrystallized from ethanol, acetone, ethyl acetate or acetonitrile.
The 1H and 13C NMR spectra and the HMBC spectra of aza-stilbenes 1a to 1g are shown in Supplementary Materials Figures S1 and S2, respectively.
4-{[(4-hydroxyphenyl)imino]methyl}phenol (1a): recrystallized from acetone; yield 63%; m.p. 212–214 °C. IR: 3485.4 (ν/O-H), 1639.3 (ν/C = N), 1239.5 (ν/C-O). 1H NMR (DMSO-d6) δ: 10.00 (s, 1H, CPh OH), 9.38 (s, 1H, NPh OH), 8.43 (s, 1H, CH = N), 7.72 (d, 2H, J = 8.61 Hz, CPh 2,6-H), 7.11 (d, 2H, J = 8.72 Hz, NPh 2,6-H), 6.85 (d, 2H, J = 8.58 Hz, CPh 3,5-H), 6.77 (d, 2H, J = 8.72 Hz, NPh 3,5-H). 13C NMR (DMSO-d6) δ: 160.1 (CPh C-1), 156.9 (C = N), 155.7 (NPh C-1), 143.2 (NPh C-4), 130.1 (CPh C-2,6), 127.9 (CPh C-4), 122.1 (NPh C-2,6), 115.6 (NPh C-3,5), 115.5 (CPh C-3,5). HRMS (ESI+) m/z: 214.0861 [M + H]+ calc. for C13H12NO2+, 214.0863, found 214.0861.
3-{[(4-Hydroxyphenyl)imino]methyl}phenol (1b): no recrystallization; yield 87%; m.p. 193–195 °C. IR: 3296.5 (ν/O-H), 1622.2 (ν/C = N), 1214.7 (ν/C-O). 1H NMR (DMSO-d6) δ: 9.61 (s, 1H, CPh OH), 9.47 (s, 1H, NPh OH), 8.50 (s, 1H, CH = N), 7.32 (m, 1H, CPh 4-H), 7.28 (s, 1H, CPh 6-H), 7.27 (m, 1H, CPh 2-H), 7.17 (d, 2H, J = 8.70 Hz, NPh 2,6-H), 6.90–6.86 (m, 1H, CPh 5-H), 6.79 (d, 2H, J = 8.70 Hz, NPh 3,5-H). 13C NMR (DMSO-d6) δ: 157.6 (CPh C-1), 157.2 (C = N), 156.2 (NPh C-1), 142.6 (NPh C-4), 137.8 (CPh C-3), 129.7 (CPh C-6), 122.5 (NPh C-2,6), 119.9 (CPh C-2), 118.1 (CPh C-5), 115.7 (NPh C-3,5), 113.9 (CPh C-4). HRMS (ESI+) m/z: 214.0862 [M + H]+ calc. for C13H12NO2+, 214.0863, found 214.0862.
2-{[(4-Hydroxyphenyl)imino]methyl}phenol (1c): no recrystallization; yield 11%; m.p. 138–139 °C. IR: 3392.1 (ν/O-H), 3280.5 (ν/O-H), 1613.8 (ν/C = N), 1209.1 (ν/C-O). 1H NMR (DMSO-d6) δ: 13.41 (s, 1H, CPh OH), 9.67 (s, 1H, NPh OH), 8.90 (s, 1H, CH = N), 7.59 (dd, 1H, J = 7.67, 1.62 Hz, CPh 6-H), 7.37 (m, 1H, CPh 5-H), 7.32 (d, 2H, J = 8.77 Hz, NPh 2,6-H), 6.96 (d, 1H, J = 7.40 Hz, CPh 3-H), 6.93 (d, 1H, J = 8.31 Hz, CPh 4-H), 6.84 (d, 2H, J = 8.75 Hz, NPh 3,5-H). 13C NMR (DMSO-d6) δ: 160.7 (C = N), 160.6 (CPh C-1), 157.4 (NPh C-1), 139.7 (NPh C-4), 133.0 (CPh C-5), 132.7 (CPh C-6), 123.1 (NPh C-2,6), 119.9 (CPh C-2), 119.4 (CPh C-3), 116.9 (CPh C-4), 116.4 (NPh C-3,5). HRMS (ESI+) m/z: 214.0861 [M + H]+ calc. for C13H12NO2+, 214.0863, found 214.0 861.
5-{[(4-Hydroxyphenyl)imino]methyl}benzene-1,3-diol (1d): washed with hot ethyl acetate; yield 60%; m.p. decomposed at 238 °C. IR: 3481.2 (ν/O-H), 3273.2 (ν/O-H), 1624.0 (ν/C = N), 1213.8 (ν/C-O). 1H NMR (DMSO-d6) δ: 9.46 (s, 1H, NPh OH), 9.44 (s, 2H, CPh OH), 8.39 (s, 1H, CH = N), 7.16 (d, 2H, J = 8.71 Hz, NPh 2,6-H), 6.78 (d, 2H, J = 8.71 Hz, NPh 3,5-H), 6.76 (d, 2H, J = 2.20 Hz, CPh 2,6-H), 6.32 (t, 1H, J = 2.21 Hz, CPh 4-H). 13C NMR (DMSO-d6) δ: 158.6 (C = N), 157.4 (CPh C-1), 156.1 (NPh C-1), 142.6 (NPh C-4), 138.3 (CPh C-3,5), 122.5 (NPh C-2,6), 115.7 (NPh C-3,5), 106.4 (CPh C-2,6), 105.2 (CPh C-4). HRMS (ESI+) m/z: 230.0811 [M + H]+ calc. for C13H12NO3+, 230.0812, found 230.0811.
4-{[(4-Hydroxyphenyl)imino]methyl}anisole (1e): recrystallized from ethanol; yield 40%; m.p. 188–190 °C. IR: 1602.8 (ν/C = N), 1221.3 (ν/C-O). 1H NMR (DMSO-d6) δ: 9.42 (s, 1H, OH), 8.51 (s, 1H, CH = N), 7.83 (d, 2H, J = 8.75 Hz, CPh 2,6-H), 7.15 (d, 2H, J = 8.67 Hz, NPh 2,6-H), 7.04 (d, 2H, J = 8.70 Hz, CPh 3,5-H), 6.78 (d, 2H, J = 8.67 Hz, NPh 3,5-H), 3.82 (s, 3H, CH3). 13C NMR (DMSO-d6) δ: 161.5 (CPh C-1), 156.6 (C = N), 155.9 (NPh C-1), 143.0 (NPh C-4), 130.0 (CPh C-2,6), 129.4 (CPh C-4), 122.3 (NPh C-2,6), 115.7 (NPh C-3,5), 114.2 (CPh C-3,5), 55.4 (CH3). HRMS (ESI+) m/z: 228.1018 [M + H]+ calc. for C14H14NO2+, 228.1019, found 228.1018.
4-{[(4-Hydroxyphenyl)imino]methyl}bromobenzene (1f): recrystallized from acetonitrile; yield 33%; m.p. 205–206 °C. IR: 1618.7 (ν/C = N), 1223.9 (ν/C-O). 1H NMR (DMSO-d6) δ: 9.54 (s, 1H, OH), 8.61 (s, 1H, CH = N), 7.84 (d, 2H, J = 8.48 Hz, CPh 2,6-H), 7.70 (d, 2H, J = 8.40 Hz, CPh 3,5-H), 7.22 (d, 2H, J = 8.70 Hz, NPh 2,6-H), 6.80 (d, 2H, J = 8.70 Hz, NPh 3,5-H). 13C NMR (DMSO-d6) δ: 156.5 (CPh C-1), 155.9 (C = N), 142.2 (NPh C-1), 135.7 (NPh C-4), 131.8 (CPh C-3,5), 130.0 (CPh C-2,6), 124.3 (CPh C-4), 122.7 (NPh C-2,6), 115.7 (NPh C-3,5). HRMS (ESI+) m/z: 276.0018 [M + H]+ calc. for C13H11NOBr+, 276.0019, found 276.0018.
2-{[(4-Hydroxyphenyl)imino]methyl}bromobenzene (1g): recrystallized from acetonitrile; yield 35%; m.p. 152–153 °C. IR: 1613.7 (ν/C = N), 1236.2 (ν/C-O). 1H NMR (500 MHz, DMSO-d6) δ: 9.62 (s, 1H, OH), 8.79 (s, 1H, CH = N), 8.11 (dd, 1H, J = 7.75 Hz, CPh 6-H), 7.74 (dd, 1H, J = 7.94 Hz, CPh 63H), 7.50 (t, 1H, J = 7.43 Hz, CPh 5-H), 7.44 (td, 1H, J = 7.61 Hz, CPh 4-H), 7.23 (d, 2H, J = 8.73 Hz, NPh 2,6-H), 6.83 (d, 2H, J = 8.73 Hz, NPh 3,5-H). 13C NMR (126 MHz, DMSO-d6) δ: 156.9 (CPh C-1), 155.0 (C = N), 142.2 (NPh C-1), 134.3 (CPh C-2), 133.2 (CPh C-3), 132.6 (CPh C-4), 128.5 (CPh C-6), 128.1 (CPh C-5), 125.0 (NPh C-4), 122.7 (NPh C-2,6), 115.9 (NPh C-3,5). HRMS (ESI+) m/z: 276.0018 [M + H]+ calc. for C13H11NOBr+, 276.0019, found 276.0018.

4.2. Cell Culture and Treatments

The mouse neuro-2a (N2a) neuroblastoma cell line (Ref: CCL-131, American Type Culture Collection (ATCC), Manassas, VA, USA) was maintained in Dulbecco’s modified Eagle medium (DMEM, Lonza, Amboise, France) containing 10% (v/v) of heat-inactivated fetal bovine serum (FBS) (Pan Biotech, Aidenbach, Germany) (30 min, 56 °C) and 1% (v/v) of penicillin (100 U/mL)/streptomycin (100 mg/mL) (Pan Biotech). The cells were incubated at 37 °C in a humidified atmosphere (5% CO2, 95% air) and passaged twice a week. The cells were seeded at 60,000 cells per well containing 1 mL of DMEM supplemented with 10% (v/v) heat-inactivated FBS and 1% antibiotics (penicillin, streptomycin) in 24-well plates (FALCON, Becton Dickinson, Franklin Lakes, NJ, USA). The stock solutions of resveratrol (trans-resveratrol, RSV) and aza-stilbenes (AZA-ST 1a to 1g) were prepared as follows: resveratrol (reference of the product: 501-36-0; purity 99%; Sigma-Aldrich, St Quentin-Fallavier, France) was prepared at 50 mM in absolute ethanol (EtOH; Carlo Erba Reagents, Val de Reuil, France); AZA-ST 1a to 1g were prepared at 50 mM in dimethyl sulfoxide (DMSO; Sigma-Aldrich). The aspects of resveratrol and aza-stilbenes in solution are shown in supplementary Figure S3. In order to evaluate the effects of aza-stilbenes on N2a cells comparatively to resveratrol (effects on cell density, esterase activity and transmembrane mitochondrial potential (ΔΨm)), the growth medium was removed after 24 h of culture and the N2a cells were incubated either with resveratrol or aza-stilbenes used at various concentrations ranging from 1.5 to 100 μM for 48 h. The highest concentration of 100 µM is obtained by diluting 16 µL of stock solution (resveratrol or aza-stilbene; stock solution at 50 mM) in 8 mL of culture medium. Concentrations of 50 to 1.5 μM are obtained by successive dilution in cascade of two by two in culture medium. The effects of vehicles (DMSO, ethanol) were evaluated at their highest concentration (0.2% v/v).

4.3. Measurement of Cell Density: Sulforhodamine 101 (SR101) Assay

Sulforhodamine 101 (SR101) (reference of the product: S7635, Sigma Aldrich) assay was used to assess the cytotoxic effect of resveratrol and AZA-ST on N2a cells at different concentrations ranging from 1.5 to 100 µM. SR101 is an anionic dye that electrostatically binds to cellular proteins [35,36]. SR101 permits the quantification of adherent cells, considered as viable cells, since cell death is associated with a loss of cell adhesion. The experiments were realized four times in triplicate. The data were expressed as percentage of the control.

4.4. Measurement of Esterase Activity: Fluorescein Diacetate (FDA) Assay

Cell viability was measured with the fluorescein diacetate (FDA) (reference of the product: F1303, Invitrogen/Molecular Probes) assay, which considers esterase [35,41]. The N2a cells, previously cultured for 24 h in 24-well plates in DMEM containing 10% FBS, were further incubated for 48 h, with and without resveratrol, or AZA-ST, used at different concentrations (1.5 to 100 μM). At the end of treatment, cells were incubated in the dark with 15 µg/mL FDA for 5 min at 37 °C, rinsed twice with phosphate buffered saline (PBS), then lysed with 10 mM Tris-HCl solution containing 1% sodium dodecyl containing 1% sodium dodecyl sulfate (SDS) for 10 min. Using a TECAN fluorescence microplate reader (Sunrise spectrophotometer, TECAN, Lyon, France), the fluorescence intensity was measured with an excitation at 485 nm and an emission at 528 nm. All assays were performed in three independent experiments and performed in triplicate. Data were expressed as percentage of untreated cells (control).

4.5. Measurement of Transmembrane Mitochondrial Potential (ΔΨm): 3,3′-Dihexyloxacarbocyanine IODIDE (DiOC6(3)) Assay

The variation of the mitochondrial transmembrane potential (∆Ψm) was measured using 3,3′-dihexyloxacarbocyanine iodide (DiOC6(3)) (D273, Invitrogen/Thermo Fisher Scientific, Montigny le Bretonneux, France). This fluorochrome accumulates in the mitochondria proportionally to the ΔΨm value [42]. The higher the ∆Ψm, the more the probe accumulates. After 48 h of treatment, adherent cells collected by trypsinization were pooled with non-adherent cells and stained with a solution of DiOC6(3) at 40 nM (15 min; 37 °C). The cells were immediately analyzed on a BD Accuri™ C6 flow cytometer (BD Biosciences, San Jose, CA, USA). The loss of ∆Ψm is indicated by a decrease in the intensity of the green fluorescence collected through a band pass filter of 520 ± 10 nm. For each sample, 10,000 cells were acquired, and the data were analyzed with FlowJo (Tree Star Inc., Carrboro, NC, USA) software. All assays were performed in triplicate.

4.6. Measurement of Antioxidant Activity with the KRL (Kit Radicaux Libres) Assay

The KRL (Kit Radicaux Libres) test was used to assess the oils’ overall antioxidant activity by their ability to protect erythrocytes against a controlled free radical attack at varying concentrations [20,21]. Diluted control blood samples were exposed to organic free radicals generated at 37 °C from the thermal decomposition of a solution of 2.2′–azobis (2-amidinopropane) dihydrochloride (AAPH). In order to record haemolysis, the turbidimetric optical density decline at 620 nm was measured using a 96-well microplate reader (KRL Reader, Kirial International; Couternon, France). The antioxidant activity of the tested oil samples was expressed in Trolox equivalents and gallic acid equivalent. Lara-Spiral laboratory performed the KRL test (Couternon, France).

4.7. Measurement of Antioxidant Activity with the DPPH (2,2′-Diphenyl-1-Picrylhydrazyl Radical) Assay

The DPPH• radical is a stable soluble molecule characterized by its deep-violet color, with an absorption maximum at 515 nm. Antioxidants (AH) or other radical species (R•) are able to react with this stable radical (DPPH•) by providing an electron or hydrogen atom, thus reducing it to 2,2-diphenyl-1-hydrazine (DPPH-H) or a substituted analogous hydrazine (DPPH-R) characterized by colorless or pale-yellow color that could be easily monitored with a spectrophotometer. In the present study, the free radical scavenging activity was determined by the DPPH assay as previously described [22]. DPPH• was prepared in 95% methanol and protected from light. In 96-well plates, 40 µL of DPPH (0.2 mmol/L) was added to 160 µL of sample or blank, and the mixture was homogenized and left to stand in the dark for 30 min. Absorbance was measured using a spectrophotometer at 517 nm, and DPPH• radical scavenging activity was expressed as a percent of inhibition (PI) using the following equation:
PI = [(A0 − A1)/A0] × 100
where A0 is the absorbance of the DPPH solution, and A1 is the absorbance of the DPPH solution after the addition of the sample. All assays were performed in three independent experiments and performed in triplicate.

4.8. Measurement of Antioxidant Activity with the Ferric Reducing Antioxidant (FRAP) Assay

Ferric reducing antioxidant power (FRAP) is based on the reduction of Fe3+ (ferric ions) to Fe2+ (ferrous ions), and the assay was carried using previously described methods [23,24]. At low pH, in the presence of 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ, Sigma Aldrich, France), the ferric-tripyridyltriazine complex (Fe3+-TPTZ) is reduced to ferrous (Fe2+-TPTZ) with the formation of an intense blue color with an absorption maximum at 593 nm. Briefly, 2.3 mL of FRAP reagent (contains 100 mL of 0.3 M acetate buffer, pH 3.6; 20 mL of 10 mM TPTZ solution in 40 mM HCl; and 20 mL of 20 mM FeCl3) was mixed with 0.7 mL of the product (resveratrol or aza-stilbene 1a1g) at different concentrations. The mixture was then incubated at 37 °C for 30 min in the dark. The absorbance was measured at 593 nm against a blank containing all the reagents, except the sample, using a spectrophotometer (Safas Xenus, Monaco). The increase in absorbance of the reaction mixture indicates an increase in reduction capacity. Results of the samples were expressed as µMol Fe2+ reduced per mM of resveratrol and aza-stilbenes from a standard calibration curve of FeSO4∙7H2O.

4.9. Measurement of Antioxidant Activity with the PAOT Liquid® Technology Assay

The total antioxidant power of resveratrol and aza-stibenes was also determined by PAOT Liquid® Technology (patent FR1871986; 11.28.2018; https://worldwide.espacenet.com/patent/search/family/066776410/publication/US2022031230A1?q=FR1871986; accessed on 19 July 2022). This method was based on an electrochemical reaction with a molecule in a free radical state (mediator M•), following Equation 1 (Equation (1)) [25].
Oxidized mediator M• + AOX → Reduced mediator M + oxidized AOX
Analysis was started with electrochemical potential measurement (EP control t0) of the reaction medium (1 mL), and then 20 µL of sample was added. The potential product (EP product t4) was registered after 4 min of interaction between the sample that contains antioxidants and reduced mediator M•
The variation ratio of the oxidized and reduced forms of the mediator M• during reaction gives an estimation of antioxidant activity in the sample by using Equation 2 (Equation (2))
Antioxidant activity = X 100%
The results were expressed as PAOT score per liter (PAOT Score/L) of the analyzed sample.

4.10. Statistical Analysis

The experimental results were statistically analyzed with GraphPad Prism 8.0 software (GraphPad Software, San Diego, CA, USA). Data were expressed as the mean ± standard deviation (SD) and compared with a Student’s t-test. A p-value less than 0.05 was considered statistically significant.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27154713/s1, 1H (500 MHz), 13C (126 MHz) NMR and HMBC-NMR spectra of the seven aza-stilbenes synthethized; aspects of resveratrol and aza-stilbenes in solution.

Author Contributions

Conceptualization, A.V., G.L. and D.V.-F.; methodology, A.V., G.L. and D.V.-F.; Investigation/Experimental work: M.K., T.N., I.G., S.M., E.P.-C., P.D., D.V.-F. and D.D.; Discussion: N.L., M.P., G.L., A.V., and D.V.-F.; writing—original draft preparation, A.V., G.L. and D.V.-F.; funding acquisition, A.V., G.L., T.G., O.M.-K. and D.V.-F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Université de Bourgogne (G.L., A.V., D.V.-F.), Région Bourgogne Franche-Comté (Projet MEDICTA, Appel à Projet Région 2020, G.L., A.V., D.V.-F.), Institut de Chimie Moléculaire de l’Université de Bourgogne ICMUB UMR CNRS 6302 (D.V.-F.). M.K. received financial support from PHC Utique (G.L./T.G. and O.M.-K.; 2021–2022; code CMCU22G089/code Campus France 47608V).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are available at the Institute of Molecular Chemistry of University of Burgundy (ICMUB UMR CNRS 6302; Dijon, France) and at Laboratory Bio-peroxIL (University of Burgundy/Inserm, Dijon, France).

Acknowledgments

Imen Ghzaiel (I.G.) received financial support from Nutrition Méditerranéenne et Santé Association (NMS; Norbert Latruffe.), and Institut Européen des Antioxydants (IEA, Smail Meziane). I.G. and Mohamed Ksila (M.K.) received financial support from ABASIM (Association Bourguignonne pour les Applications des Sciences de l’Information en Médecine; Dijon, France). G.L. is member of the International Natural Product Sciences Taskforce (INPST: https://inpst.net/ accessed on 20 April 2022). G.L. and N.L. are members of the international network of the UNESCO Chair ’Culture and tradition of wine’ (http://chaireunesco-vinetculture.u-bourgogne.fr/ accessed on 20 May 2022).

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 1a1g are available from the authors.

References

  1. Quideau, S.; Deffieux, D.; Douat-Casassus, C.; Pouységu, L. Plant polyphenols: Chemical properties, biological activities and synthesis. Angew. Chem. 2011, 50, 596–621. [Google Scholar] [CrossRef] [PubMed]
  2. Lucarini, M.; Durazzo, A.; Lombardi-Boccia, G.; Souto, E.B.; Cecchini, F.; Santini, A. Wine plolyphenols and health: Quantitative research literature analysis. Appl. Sci. 2021, 11, 4762. [Google Scholar] [CrossRef]
  3. Gao, Y.; Yu, X.; Wang, B.; Yin, G.; Wang, J.; Wang, T.; Bi, K. Based on multi-activity integrated strategy to screening, characterization and quantification of bioactive compounds from red wine. Molecules 2021, 26, 6750. [Google Scholar] [CrossRef]
  4. Colica, C.; Milanovic, M.; Milié, N.; Aiello, V.; De Lorenzo, A.; Abenavoli, L. A systematic review on natural antioxidant properties of resveratrol. Nat. Prod. Commun. 2018, 13, 1195–1203. [Google Scholar] [CrossRef]
  5. Yamine, A.; Namsi, A.; Vervandier-Fasseur, D.; Mackrill, J.J.; Lizard, G.; Latruffe, N. Polyphenols of the mediterranean diet and their metabolites in the prevention of colorectal cancer. Molecules 2021, 26, 3483. [Google Scholar] [CrossRef] [PubMed]
  6. Pezzuto, J.M. Resveratrol: Twenty years of growth, development and controversy. Biomol. Ther. 2019, 27, 1–14. [Google Scholar] [CrossRef] [PubMed]
  7. Walle, T. Bioavailability of resveratrol. Ann. N.Y. Acad. Sci. 2011, 1215, 9–15. [Google Scholar] [CrossRef]
  8. Cardile, V.; Chillemi, R.; Lombardo, L.; Sciuto, S.; Spatafora, C.; Tringali, C. Antiproliferative activity of methylated analogues of E- and Z-resveratrol. Z. Naturforsch. C 2007, 62, 189–195. [Google Scholar] [CrossRef]
  9. Liu, Q.; Kim, C.T.; Jo, Y.H.; Kim, S.B.; Hwang, B.Y.; Lee, M.K. Synthesis and biological evaluation of resveratrol derivatives as melanogenesis inhibitors. Molecules 2015, 20, 16933–16945. [Google Scholar] [CrossRef]
  10. Nawaz, W.; Zhou, Z.; Deng, S.; Ma, X.; Ma, X.; Li, C.; Shu, X. Therapeutic versatility of resveratrol derivatives. Nutrients 2017, 9, 1188. [Google Scholar] [CrossRef]
  11. Chalal, M.; Vervandier-Fasseur, D.; Meunier, P.; Cattey, H.; Hierso, J.C. Syntheses of polyfunctionalized resveratrol derivatives using Wittig and Heck protocols. Tetrahedron 2012, 68, 3899–3907. [Google Scholar] [CrossRef]
  12. Chalal, M.; Klinguer, A.; Echairi, A.; Meunier, P.; Vervandier-Fasseur, D.; Adrian, M. Antimicrobial activity of resveratrol analogues. Molecules 2014, 19, 7679–7688. [Google Scholar] [CrossRef] [PubMed]
  13. Chalal, M.; Delmas, D.; Meunier, P.; Latruffe, N.; Vervandier-Fasseur, D. Inhibition of cancer derived cell lines proliferation by newly synthesized hydroxylated stilbenes and ferrocenyl-stilbene analogs. Comparison with resveratrol. Molecules 2014, 19, 7850–7868. [Google Scholar] [CrossRef] [PubMed]
  14. Latruffe, N.; Vervandier-Fasseur, D. Strategic syntheses of vine and wine resveratrol derivatives to explore their effects on cell functions and dysfunctions. Diseases 2018, 6, 110. [Google Scholar] [CrossRef]
  15. Belluti, F.; Fontana, G.; Dal Bo, L.; Carenini, N.; Giommarelli, C.; Zunino, F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapopoptic agents. Bioorg. Med. Chem. 2010, 18, 3543–3550. [Google Scholar] [CrossRef]
  16. Bellina, F.; Guazzelli, N.; Lessi, M.; Manzini, C. Imidazole analogues of resveratrol: Synthesis and cancer cell growth evaluation. Tetrahedron 2015, 71, 2298–2305. [Google Scholar] [CrossRef]
  17. Li, C.; Xu, X.; Wang, X.J.; Pan, Y. Imine resveratrol analogues: Molecular design, Nrf2 activation and SAR analysis. PLoS ONE 2014, 9, e101455. [Google Scholar]
  18. Bae, S.J.; Ha, Y.M.; Kim, J.A.; Park, J.Y.; Ha, T.K.; Park, D.; Chun, P.; Park, N.H.; Moon, H.R.; Chung, H.Y. A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydrophenyl)diazinyl)phenyl-4-methylbenzenesulfonate as an azo-resveratrol analog. Biosci. Biotechnol. Biochem. 2013, 77, 65–72. [Google Scholar] [CrossRef]
  19. Lizard, G.; Latruffe, N.; Vervandier-Fasseur, D. Aza- and Azo-stilbenes: Bio-isosteric analogs of resveratrol. Molecules 2020, 25, 605. [Google Scholar] [CrossRef]
  20. Zhang, Y.; Zou, B.; Pan, Y.; Liang, H.; Yi, X.; Wang, H. Antioxidant activities and transition metal ion chelating studies of some hydroxyl Schiff base derivatives. Med. Chem. Res. 2012, 21, 1341–1346. [Google Scholar] [CrossRef]
  21. Siddiqui, A.; Dandawate, P.; Rub, R.; Padhye, S.; Aphale, S.; Moghe, A.; Jagyasi, A.; Swamy, K.V.; Singh, B.; Chatterjee, A.; et al. Novel aza-resveratrol analogs: Synthesis, characterization and anti-cancer activity against breast cancer cell lines. Bioorg. Med. Chem. Lett. 2013, 23, 635–640. [Google Scholar] [CrossRef]
  22. Ronghe, A.; Chatterjee, A.; Singh, B.; Dandawate, P.; Murphy, L.; Bhat, N.K.; Padhye, S.; Bhat, H.K. Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene-1,2-diol}, a novel resveratrol analog. J. Steroid Biochem. Mol. Biol. 2014, 144, 500–512. [Google Scholar] [PubMed]
  23. Tanaka, K.; Shiraishi, R. Clean and efficient condensation reactions of aldehydes and amines in a water suspension medium. Green Chem. 2000, 2, 272–273. [Google Scholar] [CrossRef]
  24. Lu, J.; Li, C.; Chai, Y.F.; Yang, D.Y.; Sun, C.R. The anti-oxidant effect of imine resveratrol analogues. Bioorg. Med. Chem. Lett. 2012, 22, 5744–5747. [Google Scholar] [CrossRef] [PubMed]
  25. Kotora, P.; Sersen, F.; Filo, J.; Loos, D.; Gregan, J.; Gregan, F. The scavenging of DPPH, galvinoxyl and ABTS radicals by imine analogs of resveratrol. Molecules 2016, 21, 127. [Google Scholar] [CrossRef]
  26. Yammine, A.; Zarrouk, A.; Nury, T.; Vejux, A.; Latruffe, N.; Vervandier-Fasseur, D.; Samadi, M.; Mackrill, J.J.; Greige-Gerges, H.; Auezova, L.; et al. Prevention by Dietary Polyphenols (Resveratrol, Quercetin, Apigenin) Against 7-Ketocholesterol-Induced Oxiapoptophagy in Neuronal N2a Cells: Potential Interest for the Treatment of Neurodegenerative and Age-Related Diseases. Cells 2020, 9, 2346. [Google Scholar] [CrossRef]
  27. Zarrouk, A.; Martine, L.; Grégoire, S.; Nury, T.; Meddeb, W.; Camus, E.; Badreddine, A.; Durand, P.; Namsi, A.; Yammine, A.; et al. Profile of Fatty Acids, Tocopherols, Phytosterols and Polyphenols in Mediterranean Oils (Argan Oils, Olive Oils, Milk Thistle Seed Oils and Nigella Seed Oil) and Evaluation of their Antioxidant and Cytoprotective Activities. Curr. Pharm. Des. 2019, 25, 1791–1805. [Google Scholar] [CrossRef]
  28. Alashi, A.M.; Taiwo, K.A.; Oyedele, D.J.; Adebooye, O.C.; Aluko, R.E. Polyphenol composition and antioxidant properties of vegetable leaf-fortified bread. J. Food Biochem. 2019, 43, e12625. [Google Scholar] [CrossRef]
  29. Dudonne, S.; Vitrac, X.; Coutière, P.; Woillez, M.; Mérillon, J.M. Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays. J. Agric Food Chem. 2009, 57, 1768–1774. [Google Scholar] [CrossRef]
  30. Benzie, I.F.; Strain, J.J. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999, 299, 15–27. [Google Scholar]
  31. Pincemail, J.; Kaci, M.-M.; Kevers, C.; Tabart, J.; Elle, R.E.; Meziane, S. PAOT-Liquid® Technology: An Easy Electrochemical Method for Evaluating Antioxidant Capacity of Wines. Diseases 2019, 7, 10. [Google Scholar] [CrossRef] [PubMed]
  32. Caruso, F.; Tanski, J.; Villegas-Estrada, A.; Rossi, M. Structural basis for antioxidant activity of trans-resveratrol: Ab initio calculations and crystal and molecular structure. J. Agric. Food Chem. 2004, 52, 7279–7285. [Google Scholar] [CrossRef] [PubMed]
  33. Rossi, M.; Caruso, F.; Opazo, C.; Salciccioli, J. Crystal and molecular structure of piceatannol: Scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals docking with transthyretin. J. Agric. Food Chem. 2008, 62, 10557–10566. [Google Scholar] [CrossRef] [PubMed]
  34. Gaenko, A.V.; Devarajan, A.; Gagliardi, L.; Lindh, R.; Orlandi, G. Ab initio DFT study of Z-E isomerization pathways of N-benzylideneaniline. Theor. Chem. Acc. 2007, 118, 271–279. [Google Scholar] [CrossRef]
  35. Namsi, A.; Nury, T.; Hamdouni, H.; Yammine, A.; Vejux, A.; Vervandier-Fasseur, D.; Latruffe, N.; Masmoudi-Kouki, O.; Lizard, G. Induction of Neuronal Differentiation of Murine N2a Cells by Two Polyphenols Present in the Mediterranean Diet Mimicking Neurotrophins Activities: Resveratrol and Apigenin. Diseases 2018, 6, 67. [Google Scholar] [CrossRef] [PubMed]
  36. Yammine, A.; Nury, T.; Vejux, A.; Latruffe, N.; Vervandier-Fasseur, D.; Samadi, M.; Greige-Gerges, H.; Auezova, L.; Lizard, G. Prevention of 7-Ketocholesterol-Induced Overproduction of Reactive Oxygen Species, Mitochondrial Dysfunction and Cell Death with Major Nutrients (Polyphenols, ω3 and ω9 Unsaturated Fatty Acids) of the Mediterranean Diet on N2a Neuronal Cells. Molecules 2020, 25, 2296. [Google Scholar] [CrossRef] [PubMed]
  37. Lakey-Beitia, J.; Burillo, A.M.; La Penna, G.; Hegde, M.L.; Rao, K.S. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease. J. Alzheimers Dis. 2021, 82, S335–S357. [Google Scholar] [CrossRef]
  38. Uddin, M.S.; Mamun, A.A.; Rahman, M.M.; Jeandet, P.; Alexiou, A.; Behl, T.; Sarwar, M.S.; Sobarzo-Sánchez, E.; Ashraf, G.M.; Sayed, A.; et al. Natural Products for Neurodegeneration: Regulating Neurotrophic Signals. Oxid. Med. Cell Longev. 2021, 2021, 8820406. [Google Scholar] [CrossRef]
  39. Kaminski, J.; Lançon, A.; Aires, V.; Limagne, E.; Tili, E.; Michaille, J.J.; Latruffe, N. Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts. Biochem. Pharmacol. 2012, 84, 1251–1259. [Google Scholar] [CrossRef]
  40. Cho, M.R.; Lee, S.; Song, S.K. A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction. J. Korean Med. Sci. 2022, 37, e146. [Google Scholar] [CrossRef]
  41. Namsi, A.; Nury, T.; Khan, A.S.; Leprince, J.; Vaudry, D.; Caccia, C.; Leoni, V.; Atanasov, A.G.; Tonon, M.C.; Masmoudi-Kouki, O.; et al. Octadecaneuropeptide (ODN) Induces N2a Cells Differentiation through a PKA/PLC/PKC/MEK/ERK-Dependent Pathway: Incidence on Peroxisome, Mitochondria, and Lipid Profiles. Molecules 2019, 24, 3310. [Google Scholar] [CrossRef] [PubMed]
  42. Ragot, K.; Mackrill, J.J.; Zarrouk, A.; Nury, T.; Aires, V.; Jacquin, A.; Athias, A.; Pais de Barros, J.P.; Vejux, A.; Riedinger, J.M.; et al. Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes. Biochem. Pharmacol. 2013, 86, 67–79. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Structure of trans-resveratrol RSV, aza-stilbenes AZA-ST and azo-stilbenes AZO-ST.
Figure 1. Structure of trans-resveratrol RSV, aza-stilbenes AZA-ST and azo-stilbenes AZO-ST.
Molecules 27 04713 g001
Figure 2. Structure of aza-stilbenes 1a1g.
Figure 2. Structure of aza-stilbenes 1a1g.
Molecules 27 04713 g002
Scheme 1. Synthetic methods for obtaining aza-stilbenes AZA-ST.
Scheme 1. Synthetic methods for obtaining aza-stilbenes AZA-ST.
Molecules 27 04713 sch001
Scheme 2. Synthesis of AZA-ST 1ag.
Scheme 2. Synthesis of AZA-ST 1ag.
Molecules 27 04713 sch002
Figure 3. Evaluation with the sulforhodamine 101 (SR101) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell density. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Cell density evaluated with SR101 reflects the quantity of adherent cells. The dotted red line makes it possible to evaluate the value of the concentration or the range of concentrations reducing the number of adherent cells by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Figure 3. Evaluation with the sulforhodamine 101 (SR101) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell density. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Cell density evaluated with SR101 reflects the quantity of adherent cells. The dotted red line makes it possible to evaluate the value of the concentration or the range of concentrations reducing the number of adherent cells by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Molecules 27 04713 g003
Figure 4. Evaluation with the fluorescein diacetate (FDA) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell viability. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. The dotted red line makes it possible to evaluate the value of the concentration, or the range of concentrations, reducing cell viability by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Figure 4. Evaluation with the fluorescein diacetate (FDA) assay of the effects of resveratrol and aza-stilbenes 1a to 1g on cell viability. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. The dotted red line makes it possible to evaluate the value of the concentration, or the range of concentrations, reducing cell viability by 50% (IC50). Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Molecules 27 04713 g004
Figure 5. Flow cytometric evaluation of transmembrane mitochondrial potential (ΔΨm) with DiOC6(3) under treatment with resveratrol and aza-stilbenes 1a to 1g. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Figure 5. Flow cytometric evaluation of transmembrane mitochondrial potential (ΔΨm) with DiOC6(3) under treatment with resveratrol and aza-stilbenes 1a to 1g. N2a cells were incubated for 48 h with or without resveratrol or aza-stilbenes 1a to 1g in a range of concentrations from 1.5 to 100 µM. Data are the mean ± SD of two independent experiments performed in triplicate. Significance of the differences between control (untreated cells), Resveratrol (trans-resveratrol) or aza-stilbenes 1a to 1g–treated cells; Student’s t test: * p < 0.05 or less.
Molecules 27 04713 g005
Figure 6. Quantification of the antioxidant activity of resveratrol and aza-stilbenes 1a to 1g with the KRL test.
Figure 6. Quantification of the antioxidant activity of resveratrol and aza-stilbenes 1a to 1g with the KRL test.
Molecules 27 04713 g006
Figure 7. Symbolism for analysis of NMR data.
Figure 7. Symbolism for analysis of NMR data.
Molecules 27 04713 g007
Table 1. IC50 values of resveratrol and aza-stilbenes 1a to 1g obtained with the SR101, FDA et DiOC6(3) assays. Sulforhodamine 101 (SR101, evaluation of cell density), fluorescein diacetate (FDA, esterase activity/evaluation of cell viability) and DiOC6(3) (measurement of transmembrane mitochondrial potential (ΔΨm)). Aza-stilbenes were compared with resveratrol (trans-resveratrol).
Table 1. IC50 values of resveratrol and aza-stilbenes 1a to 1g obtained with the SR101, FDA et DiOC6(3) assays. Sulforhodamine 101 (SR101, evaluation of cell density), fluorescein diacetate (FDA, esterase activity/evaluation of cell viability) and DiOC6(3) (measurement of transmembrane mitochondrial potential (ΔΨm)). Aza-stilbenes were compared with resveratrol (trans-resveratrol).
Molecular
Formula
Molecular Weight
(g/mol)
IC50 µM
(SR101)
IC50 µM
(FDA)
IC50 µM
(DiOC6(3))
ResveratrolC14H12O3228.24~12.56.25 < IC50 < 12.5100
Aza-Stilbene 1aC13H11NO2213.22825 < IC50 < 5012.550 < IC50 < 100
Aza-Stilbene 1bC13H11NO2213.22812.512.5 < IC50 < 2550 < IC50 < 100
Aza-Stilbene 1cC13H11NO2213.2282512.5 < IC50 < 2550 < IC50 < 100
Aza-Stilbene 1dC13H11NO3229.228256.2550 < IC50 < 100
Aza-Stilbene 1eC13H10NOBr227.25425 < IC50 < 506.25 < IC50 < 12.550 < IC50 < 100
Aza-Stilbene 1fC13H10NOBr276.1125 < IC50 < 5012.550 < IC50 < 100
Aza-Stilbene1gC13H10NOBr276.116.25~12.550 < IC50 < 100
Table 2. Antioxidant activities of resveratrol and aza-stilbenes.
Table 2. Antioxidant activities of resveratrol and aza-stilbenes.
Antioxidant Activities of Resveratrol and Aza-Stilbenes 1a–1g
Evaluated with Different Assays
CompoundsKRL
(20 µM)
DPPH
(25 µM)
FRAP
(25 µM)
PAOT Score
(25 µM)
Resveratrol72.81 ± 1.1032.76 ± 6.4010.41 ± 0.0519.39 ± 1.06
Aza-stilbene 1a129.74 ± 3.9235.07 ± 1.7510.52 ± 0.0542.65 ± 0.78
Aza-stilbene 1b141.29 ± 4.6538.84 ± 1.9010.02 ± 0.0434.11 ± 0.18
Aza-stilbene 1c128.38 ± 2.035.51 ± 2.2512.32 ± 0.0613.34 ± 0.54
Aza-stilbene 1d154.63 ± 3.5047.84 ± 2.3511.05 ± 0.0756.49 ± 0.59
Aza-stilbene 1e116.06 ± 4.4048.55 ± 2.4010.34 ± 0.05ND
Aza-stilbene 1f123.78 ± 5.1653.69 ± 2.6510.41 ± 0.05ND
Aza-stilbene 1g125.76 ± 3.3917.23 ± 0.8510.18 ± 0.04ND
Aza-stilbenes and resveratrol were used either at 20 or 25 µM. No differences were observed between resveratrol and aza-stilbenes with the FRAP assays. According to the KRL assay, DPPH assay and PAOT, various antioxidant properties of aza-stilbenes and resveratrol were identified. The KRL assay is expressed as increase of haemolysis time (% of control); DPPH assay: % inhibition; FRAP assay: µMol Fe2+ reduced per mM of resveratrol and aza-stilbenes; PAOT score: (PAOT Score/L) of analyzed sample. Data are means of 1–2 independent experiments realized in triplicate. N.D: not determined.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ksila, M.; Vejux, A.; Prost-Camus, E.; Durand, P.; Ghzaiel, I.; Nury, T.; Duprey, D.; Meziane, S.; Masmoudi-Kouki, O.; Latruffe, N.; et al. Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells. Molecules 2022, 27, 4713. https://doi.org/10.3390/molecules27154713

AMA Style

Ksila M, Vejux A, Prost-Camus E, Durand P, Ghzaiel I, Nury T, Duprey D, Meziane S, Masmoudi-Kouki O, Latruffe N, et al. Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells. Molecules. 2022; 27(15):4713. https://doi.org/10.3390/molecules27154713

Chicago/Turabian Style

Ksila, Mohamed, Anne Vejux, Emmanuelle Prost-Camus, Philippe Durand, Imen Ghzaiel, Thomas Nury, Dorian Duprey, Smail Meziane, Olfa Masmoudi-Kouki, Norbert Latruffe, and et al. 2022. "Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells" Molecules 27, no. 15: 4713. https://doi.org/10.3390/molecules27154713

APA Style

Ksila, M., Vejux, A., Prost-Camus, E., Durand, P., Ghzaiel, I., Nury, T., Duprey, D., Meziane, S., Masmoudi-Kouki, O., Latruffe, N., Ghrairi, T., Prost, M., Lizard, G., & Vervandier-Fasseur, D. (2022). Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells. Molecules, 27(15), 4713. https://doi.org/10.3390/molecules27154713

Article Metrics

Back to TopTop